Tielong Gao

Title: Tielong Gao: Innovator in Pharmaceutical Aerosol Formulations

Introduction

Tielong Gao is a notable inventor based in Rancho Cucamonga, CA (US). He has made significant contributions to the field of pharmaceutical aerosol formulations, particularly in the development of inhalation therapies. His innovative work focuses on improving the delivery and efficacy of medications for respiratory conditions.

Latest Patents

Tielong Gao holds a patent for a "Stable epinephrine suspension formulation for inhalation with HFO propellant." This patent describes pharmaceutical aerosol formulations that contain pre-micronized epinephrine, co-solvent ethanol, surfactant polysorbate 80, and the propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze(E)). The formulations are designed for use in a pressurized metered dose inhaler, providing a highly efficient delivery of pre-micronized epinephrine particles into patients' respiratory tracts. The advantages of this formulation include high efficacy, improved safety, and a low global warming potential (GWP), making it environmentally friendly.

Career Highlights

Tielong Gao is currently associated with Amphastar Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health needs in the pharmaceutical industry.

Collaborations

Tielong Gao collaborates with esteemed colleagues such as Jack Yongfeng Zhang and Mary Zi-Ping Luo. Their combined expertise contributes to the success of their projects and enhances the impact of their innovations in the field.

Conclusion

Tielong Gao's contributions to pharmaceutical aerosol formulations exemplify the importance of innovation in healthcare. His work not only improves patient outcomes but also addresses environmental concerns, showcasing a commitment to both efficacy and sustainability.